StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Revenue Offset for Prior-Period Insurance Non-Refunded by Quarter

Revenue Offset for Prior-Period Insurance Non-Refunded Considerations ($M) [legacy through Q3 2025] ($M)

Natera Revenue Offset for Prior-Period Insurance Non-Refunded: $0.20M in Q3 2025, down 50.0% from a year earlier.

Latest, Q3 2025
0.20
Period ended Sep 30, 2025
Change on a year earlier
-50.0%
0.40 in Q3 2024
History
7 quarters
Since Q1 2024
Sources
4
Documents cited below

Where the Q3 2025 figure comes from

Source: Form 10-Q (2025-11-07) ↗

Reported in Form 10-K/10-Q Note — Revenue Recognition (2021–2025Q3).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRevenue Offset for Prior-Period Insurance Non-Refunded Considerations ($M) [legacy through Q3 2025] ($M)Year on yearSource
Q3 2025Sep 30, 20250.20-50.0%Form 10-Q (2025-11-07) ↗
Q2 2025Jun 30, 20250.40-33.3%Form 10-Q (2025-08-08) ↗
Q1 2025Mar 31, 20253.50-333.3%Form 10-Q (2025-05-09) ↗
Q4 2024Dec 31, 2024-0.20–Form 10-K (2025-02-28) ↗
Q3 2024Sep 30, 20240.40–Form 10-Q (2025-11-07) ↗
Q2 2024Jun 30, 20240.60–Form 10-Q (2025-08-08) ↗
Q1 2024Mar 31, 2024-1.50–Form 10-Q (2025-05-09) ↗

Cite this data

StockData. (2026). Natera Revenue Offset for Prior-Period Insurance Non-Refunded ($M), quarterly Q1 2024–Q3 2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-prior-period-insurance-nonrefunded

See every metric in the Natera KPI table. Data updated Nov 2, 2026.